scholarly journals A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma

2018 ◽  
Vol 11 (1) ◽  
Author(s):  
Wan-Hong Zhao ◽  
Jie Liu ◽  
Bai-Yan Wang ◽  
Yin-Xia Chen ◽  
Xing-Mei Cao ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Cell Therapy ◽  
Phase 1 ◽  
Cell Maturation ◽  
Open Label ◽  
T Cell Therapy ◽  
Open Label Study ◽  
Label Study ◽  
B Cell Maturation ◽  
B Cell Maturation Antigen

scholarly journals B-cell Maturation Antigen Is a Promising Target for Adoptive T-cell Therapy of Multiple Myeloma

2013 ◽  
Vol 19 (8) ◽  
pp. 2048-2060 ◽  
Author(s):  
Robert O. Carpenter ◽  
Moses O. Evbuomwan ◽  
Stefania Pittaluga ◽  
Jeremy J. Rose ◽  
Mark Raffeld ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
T Cell ◽  
Cell Therapy ◽  
B Cell ◽  
Adoptive T Cell Therapy ◽  
Cell Maturation ◽  
T Cell Therapy ◽  
B Cell Maturation ◽  
Promising Target ◽  
B Cell Maturation Antigen

scholarly journals Chimeric Antigen Receptor-Modified T Cell Therapy in Multiple Myeloma: Beyond B Cell Maturation Antigen

2019 ◽  
Vol 10 ◽  
Author(s):  
Marijke Timmers ◽  
Gils Roex ◽  
Yuedi Wang ◽  
Diana Campillo-Davo ◽  
Viggo F. I. Van Tendeloo ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
T Cell ◽  
Cell Therapy ◽  
B Cell ◽  
Chimeric Antigen Receptor ◽  
Antigen Receptor ◽  
Cell Maturation ◽  
T Cell Therapy ◽  
B Cell Maturation ◽  
B Cell Maturation Antigen
Sign in / Sign up

Export Citation Format

Share Document